000 | 01925 a2200577 4500 | ||
---|---|---|---|
005 | 20250515042546.0 | ||
264 | 0 | _c20071009 | |
008 | 200710s 0 0 eng d | ||
022 | _a0340-5761 | ||
024 | 7 |
_a10.1007/s00204-006-0153-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLevy, Aharon | |
245 | 0 | 0 |
_aExtrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. _h[electronic resource] |
260 |
_bArchives of toxicology _cMay 2007 |
||
300 |
_a353-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChemical Warfare Agents _xpoisoning |
650 | 0 | 4 |
_aCholinergic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aCyclopentanes _xblood |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 | _aLethal Dose 50 |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aOrganophosphate Poisoning |
650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
650 | 0 | 4 | _aPapio anubis |
650 | 0 | 4 |
_aPoisoning _xblood |
650 | 0 | 4 |
_aPyridostigmine Bromide _xblood |
650 | 0 | 4 |
_aSarin _xadministration & dosage |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCohen, Giora | |
700 | 1 | _aGilat, Eran | |
700 | 1 | _aKapon, Joseph | |
700 | 1 | _aDachir, Shlomit | |
700 | 1 | _aAbraham, Shlomo | |
700 | 1 | _aHerskovitz, Miriam | |
700 | 1 | _aTeitelbaum, Zvi | |
700 | 1 | _aRaveh, Lily | |
773 | 0 |
_tArchives of toxicology _gvol. 81 _gno. 5 _gp. 353-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00204-006-0153-6 _zAvailable from publisher's website |
999 |
_c16586786 _d16586786 |